» Authors » Marcia Dalastra Laurenti

Marcia Dalastra Laurenti

Explore the profile of Marcia Dalastra Laurenti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 613
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jesus J, Araujo Flores G, Souza D, Tristao D, Serrano D, Lalatsa A, et al.
Microorganisms . 2025 Feb; 13(2). PMID: 40005676
Leishmaniasis, a complex disease caused by protozoal parasites of the genus , presents various clinical forms, particularly a cutaneous clinical form. Treatment is typically performed with pentavalent antimonial and amphotericin...
2.
Fernandez-Garcia R, Walsh D, OConnell P, Passero L, de Jesus J, Laurenti M, et al.
Mol Pharm . 2025 Feb; 22(3):1437-1448. PMID: 39960049
The incidence of visceral leishmaniasis (VL) remains a significant health threat in endemic countries. Fixed-dose combination (FDC) of amphotericin B (AmB) and miltefosine (MLT) is a promising strategy for treating...
3.
Bento G, Zanfagnini L, Laurenti M, Tomokane T, Matta V, Souza S, et al.
Rev Bras Parasitol Vet . 2024 Dec; 33(4):e010824. PMID: 39630741
Canine leishmaniasis is a parasitic disease whose agents are transmitted through the bites of infected phlebotomine sand flies. This disease is endemic in tropical and subtropical regions, including Brazil. However,...
4.
Pedro Soares R, Fontes I, Dutra-Rego F, Nunes Rugani J, Moreira P, Matta V, et al.
PLoS Negl Trop Dis . 2024 Aug; 18(8):e0012333. PMID: 39121159
American tegumentary leishmaniasis (ATL) is highly endemic in the Amazon basin and occurs in all South American countries, except Chile and Uruguay. Most Brazilian ATL cases are due to Leishmania...
5.
Bonilla A, Pineda V, Calzada J, Saldana A, Laurenti M, Goya S, et al.
Microorganisms . 2024 Jul; 12(7). PMID: 39065086
() spp. can harbor a double-stranded RNA virus known as Leishmania RNA virus 1 (LRV-1), whose presence has been reported in nine countries across the Americas and seven species. Here,...
6.
Jesus J, da Silva T, Sousa I, Ferreira A, Laurenti M, da Costa P, et al.
Pharmaceuticals (Basel) . 2023 Dec; 16(12). PMID: 38139773
Leishmaniasis is a neglected tropical disease that affects millions of people around the world. Available therapy causes severe side effects, has unacceptable prices for some specific formulations, and the existence...
7.
de Lima S, Cavallone I, Serrano D, Anaya B, Lalatsa A, Laurenti M, et al.
Pharmaceutics . 2023 Nov; 15(11). PMID: 38004580
Cutaneous leishmaniasis exhibits a wide spectrum of clinical manifestations; however, only a limited number of drugs are available and include Glucantime and amphotericin B, which induce unacceptable side effects in...
8.
Rego F, da Silva E, Lopes V, Teixeira-Neto R, Belo V, Fonseca Junior A, et al.
Mem Inst Oswaldo Cruz . 2023 Sep; 118:e230071. PMID: 37729273
Background: Leishmania RNA virus 1 (LRV1) is commonly found in South American Leishmania parasites belonging to the subgenus Viannia, whereas Leishmania RNA virus 2 (LRV2) was previously thought to be...
9.
de Lima S, Jesus J, Raminelli C, Laurenti M, Passero L
Pharmaceuticals (Basel) . 2023 May; 16(5). PMID: 37242490
Leishmaniasis is a neglected disease caused by protozoa of the genus , which causes different clinical manifestations. Drugs currently used in the treatment such as pentavalent antimonial and amphotericin B...
10.
Segura G, Ochoa W, Matta V, Martinez M, Tercero C, Gonzalez R, et al.
Rev Inst Med Trop Sao Paulo . 2023 Mar; 65:e24. PMID: 36995877
Dogs are considered to be the main domestic reservoir associated with the transmission of Leishmania (L.) infantum chagasi to humans in endemic areas of visceral leishmaniasis in America. However, little...